OTC · Beverages - Non-Alcoholic

Golden Ally Lifetech Group, Inc. (AQPW) Stock

$0.00 OTC: AQPW Consumer Defensive

Golden Ally Lifetech Group, Inc., a company in its developmental stage, concentrates on innovating across advanced technologies, energy solutions, and medical equipment. Within the bioscience and sports medicine fields, it is actively developing items like Sterilal self-sanitizing devices, PASS smart denture mouth guards, portable heart attack detection units, and melanoma screening systems.

Valuation

MetricValue
Price$0.00
Market Cap$740856
P/E Ratio0.00
P/B Ratio0.37
P/S Ratio0.00
EPS (TTM)$0.00
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-149.24%
ROA-89.08%
ROCE-374.21%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.09
Current Ratio3.24

Annual Financials (USD)

Metric20142019202020212022
Revenue$0$0$0$0$0
Operating Profit$0$0$0$0$-6.0M
Net Profit$0$0$0$0$-6.0M
EPS$-0.03$-0.01$-0.02$0.00$-0.07
Op Margin—————

Balance Sheet (USD)

Metric20142019202020212022
Total Assets$5.0M$0$0$0$2.0M
Total Liabilities$2.0M$1.0M$0$0$0
Cash$0$0$0$3.0M$1.0M
Borrowings$0$0$0$0$0

Cash Flow (USD)

Metric20142019202020212022
Operating Cash Flow$0$0$0$0$-6.0M
Investing Cash Flow$0$0$0$0$-1.0M
Financing Cash Flow$0$0$0$-3.0M$5.0M
Net Cash Flow$0$0$0$0$-2.0M
Free Cash Flow$0$0$0$0$-6.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.04
FCF Yield-821.50%
Quick Ratio16.51
Interest Coverage—
Return 1Y-50.00%
Return 3Y-99.96%
Return 5Y—

Ownership

Insiders Held87.57%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALKMAlkame Holdings, Inc. $0.00 — 1.00 $864639 0.00%
BLEGBranded Legacy, Inc. $0.01 -7.28% -0.02 $16213 0.00%
DZGHDa Zhong Trading Group Holding Company $6.00 +0.00% -4.84 $2.78M 0.00%
EESOEnzyme Environmental Solutions, Inc. $0.00 — — $364601 0.00%
FBECFBEC Worldwide, Inc. $0.00 — 0.09 $585642 0.00%

About Golden Ally Lifetech Group, Inc.

Golden Ally Lifetech Group, Inc., a company in its developmental stage, concentrates on innovating across advanced technologies, energy solutions, and medical equipment. Within the bioscience and sports medicine fields, it is actively developing items like Sterilal self-sanitizing devices, PASS smart denture mouth guards, portable heart attack detection units, and melanoma screening systems. Additionally, the company provides the InCharge magnetic battery device for energy, and is making progress on graphene-based de-icing applications for the aviation industry. Founded in 2003 and headquartered in Austin, Texas, the firm was formerly known as Signet International Holdings, Inc. until it rebranded in July 2022.

Golden Ally Lifetech Group, Inc. (AQPW) stock trades at $0.00 with a market capitalization of $740856. The stock is valued at price-to-book of 0.37, price-to-sales of 0.00.

On profitability, Golden Ally Lifetech Group, Inc. generates a return on equity (ROE) of -149.24% (negative, reflecting a net loss), return on capital employed of -374.21%.

Official website: goldenaltg.com

Related Consumer Defensive Stocks

WMT Walmart Inc. $111.35 +0.71% COST Costco Wholesale Corporation $951.90 +0.53% KO Coca-Cola Company (The) $88.72 +0.76% PG Procter & Gamble Company (The) $151.49 +0.17% PM Philip Morris International Inc $201.69 +0.25% PEP PepsiCo, Inc. $125.97 -1.85% MO Altria Group, Inc. $71.86 +0.26% MNST Monster Beverage Corporation $43.39 -0.57% MDLZ Mondelez International, Inc. $60.53 +0.19% CL Colgate-Palmolive Company $88.41 +0.16% TGT Target Corporation $151.35 -1.49% DEO Diageo plc $87.43 +0.80%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Consumer Defensive StocksLow P/E Consumer Defensive StocksHigh Net Margin Consumer Defensive StocksDividend Consumer Defensive StocksLow Debt Consumer Defensive StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.